Scarica l'app Stockscreener
0.8066
5.07%
-0.0431
Dopo l'orario di chiusura:
.86
0.0534
+6.62%
Precedente Chiudi:
$0.8497
Aprire:
$0.85
Volume 24 ore:
590.08K
Relative Volume:
0.76
Capitalizzazione di mercato:
$104.49M
Reddito:
-
Utile/perdita netta:
$-35.47M
Rapporto P/E:
-1.4151
EPS:
-0.57
Flusso di cassa netto:
$-124.27M
1 W Prestazione:
+11.81%
1M Prestazione:
+1.34%
6M Prestazione:
-52.41%
1 anno Prestazione:
-78.72%
Intervallo 1D:
$0.772
$0.8999
Intervallo di 1 settimana:
$0.71
$0.8999
Portata 52W:
$0.4603
$4.44
Prokidney Corp Stock (PROK) Company Profile
Nome
Prokidney Corp
Settore
Industria
Telefono
336-999-7028
Indirizzo
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Confronta PROK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
0.8066 | 93.45M | 0 | -35.47M | -124.27M | -0.57 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-30 | Iniziato | JP Morgan | Neutral |
| 2024-09-10 | Iniziato | Guggenheim | Buy |
| 2024-03-07 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-07-25 | Iniziato | BTIG Research | Buy |
| 2022-12-21 | Iniziato | Jefferies | Buy |
| 2022-11-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Iniziato | UBS | Buy |
| 2022-10-14 | Iniziato | Citigroup | Buy |
| 2022-09-23 | Iniziato | BofA Securities | Buy |
| 2022-09-02 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Prokidney Corp Borsa (PROK) Ultime notizie
ProKidney quarterly loss grows as it nears two key milestones - Winston-Salem Journal
ProKidney Up 26%, Insiders Still In The Red By US$35m - simplywall.st
Wells Fargo & Company MN Purchases 18,431 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Eyes Key Developments and Strong Financial Outl - GuruFocus
ProKidney Corp. Reports Increased Losses Amid Ongoing R&D - TipRanks
PROKIDNEY CORP. SEC 10-Q Report - TradingView
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Barclays PLC - Defense World
Mariner LLC Has $64,000 Stake in ProKidney Corp. (NASDAQ:PROK) - The AM Reporter
Mariner LLC Sells 15,937 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
PROKIDNEY Earnings Preview: Recent $PROK Insider Trading, Hedge Fund Activity, and More - Nasdaq
ProKidney Corp. (NASDAQ:PROK) Shares Bought by Renaissance Technologies LLC - Defense World
JPMorgan Chase & Co. Buys 19,585 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (PROK) Expected to Announce Quarterly Earnings on Friday - Defense World
The ProKidney Corp (PROK) had a good session last reading, didn’t it? - uspostnews.com
ProKidney Corp (PROK) receives a Neutral rating from JP Morgan - knoxdaily.com
ProKidney Corp Inc. (PROK) Price Performance: The Role of Supply and Demand - investchronicle.com
Gaining Ground: ProKidney Corp (PROK) Closes Higher at 1.08, Up 4.85 - DWinneX
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Is ProKidney Corp (PROK) positioned for future growth? - Sete News
ProKidney Corp (NASDAQ:PROK)’s 12-Month Price Target Currently Stands At 6 - Marketing Sentinel
Major Investment Alert: Carso De-C Inmobiliaria Acquires ProKidney Shares! - TipRanks
ProKidney Corp [PROK] Records 50-Day SMA of $1.0283 - knoxdaily.com
The Psychology of ProKidney Corp Inc. (PROK) Price Performance: Understanding Market Sentiment - investchronicle.com
Analytical Overview: ProKidney Corp (PROK)’s Ratios Tell a Financial Story - DWinneX
Major Investment Alert: ProKidney Stock Sees New Stakeholder! - TipRanks
Major Investment Alert: ProKidney Stock Acquisition! - TipRanks
Major Investment Alert: ProKidney Stock Sees Significant Purchase! - TipRanks
Greensboro’s Once Great Win Is Now A ProKidney Failure - Rhino Times
Major Investment Alert: ProKidney Stock Sees Big Buy-In! - TipRanks
Control empresarial de capitales purchases $628,847 in ProKidney shares - Investing.com
Control empresarial de capitales purchases $628,847 in ProKidney shares By Investing.com - Investing.com Canada
Sei Investments Co. Makes New $69,000 Investment in ProKidney Corp. (NASDAQ:PROK) - Defense World
Critical Review: Candel Therapeutics (NASDAQ:CADL) & ProKidney (NASDAQ:PROK) - Defense World
PROK stock touches 52-week low at $0.49 amid market challenges - Investing.com India
Institutional owners may take dramatic actions as ProKidney Corp.'s (NASDAQ:PROK) recent 32% drop adds to one-year losses - simplywall.st
Bank of New York Mellon Corp Has $388,000 Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) - Yahoo Finance
PROK stock touches 52-week low at $0.94 amid market challenges - Investing.com India
ProKidney Corp reports results for the quarter ended December 31Earnings Summary - TradingView
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty - TipRanks
ProKidney Corp (PROK) Reports $163.3 Million Net Loss for 2024, - GuruFocus.com
ProKidney reports larger loss in 2024 as production resumes - Winston-Salem Journal
PROKIDNEY CORP. SEC 10-K Report - TradingView
ProKidney CEO cites 'significant progress' after regenerative medicine company loses $163M in 2024 - The Business Journals
ProKidney reports FY24 EPS (62c), consensus (59c) - TipRanks
ProKidney Corp. Reports 2024 Financial Results and Milestones in Rilparencel Development for Chronic Kidney Disease - Nasdaq
ProKidney Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewswire
FDA Fast-Tracks ProKidney's CKD Treatment: $358M War Chest Fuels Breakthrough Development - StockTitan
Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
Prokidney Corp Azioni (PROK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):